The Joint Clinical Assessment Affect on European Patient Access
Find out what the new Joint Clinical Assessment from the European Union could mean for accelerating patient access to innovative medicines.
Pharmacovigilance AI Best Practices: How to Apply the EU AI Act 2023
Read into the latest PV AI Best Practices, discover how to apply the EU AI Act 2023.
Podcast: Considerations for How AI Will Impact Your Brand’s Patient Services
UBC talked to Pharmaceutical Commerce about what artificial intelligence capabilities could do to impact patient access in 2024 and beyond.
FDA Finalizes Guidance On Registries’ Contributions to Regulatory Submissions
Read into the implications of the latest guidance from the FDA on registries usefulness for various purposes and how to best build one.
How to Introduce AI-Powered Analytics to Patient Services
Utilizing AI-powered analytics for your patient services data can help unlock benefits that ultimately improve patient outcomes.
Real-World Evidence Opportunities for Emerging Biotech
The use of real-world evidence has greatly expanded in recent years but is still underutilized by emerging biotechs.
KAB Surveys: Establishing a Threshold of Demonstrated Understanding
Learn more about how to utilize Knowledge, Attitude, and Behavior Surveys to evaluate stakeholders in your REMS program.
A Focus on Pharmacies to Optimize Your Copay Program
With recent changes for pharmacists and pharmacies, it is beneficial for patient access to invest in relationships with these partners.
Harness the Power of Data to Enhance Your Patient Support Program
There are numerous insights to unlock within your patient services program data – but do you know where and how to look?
Compliance with Post-Marketing Requirements is Critical to the Success of Your Therapeutic
Read about the implications of the July 2023 guidance from the FDA.
